Weekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations episode artwork

EPISODE · Aug 21, 2024 · 4 MIN

Weekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations

from Eyewire News: The Podcast · host Eyewire News

Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations • Ultrasonic Sensor Device Launched for Loss of Side Vision • Ocuvex Therapeutics Acquires Visiox Pharmaceuticals Learn more about your ad choices. Visit megaphone.fm/adchoices

Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations • Ultrasonic Sensor Device Launched for Loss of Side Vision • Ocuvex Therapeutics Acquires Visiox Pharmaceuticals Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

Weekly Headlines: Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations

0:00 4:53

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 4 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on August 21, 2024.

What is this episode about?

Gene Therapies for IRDs Receive FDA Rare Pediatric Disease Designations • Ultrasonic Sensor Device Launched for Loss of Side Vision • Ocuvex Therapeutics Acquires Visiox Pharmaceuticals Learn more about your ad choices. Visit megaphone.fm/adchoices

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!